참고문헌
- Fregonesi PA, Teresa DB, Duarte RA, Neto CB, de Oliveira MR, Soares CP. p16(INK4A) immunohistochemical overexpression in premalignant and malignant oral lesions infected with human papillomavirus. J Histochem Cytochem 2003;51:1291-7. https://doi.org/10.1177/002215540305101006
- Peghini PE, Fehr J. Analysis of cyclin D1 expression by quantitative real-time reverse transcription-polymerase chain reaction in the diagnosis of mantle cell lymphoma. Am J Clin Pathol 2002;117:237-45. https://doi.org/10.1309/R2BC-2H7T-7KB6-0YG8
- Todd R, Hinds PW, Munger K, Rustgi AK, Opitz OG, Suliman Y, et al. Cell cycle dysregulation in oral cancer. Crit Rev Oral Biol Med 2002;13:51-61. https://doi.org/10.1177/154411130201300106
- Hosokawa Y, Arnold A. Cyclin D1/PRAD1 as a central target in oncogenesis. J Lab Clin Med 1996;127:246-52. https://doi.org/10.1016/S0022-2143(96)90092-X
- Fracchiolla NS, Pruneri G, Pignataro L, Carboni N, Capaccio P, Boletini A, et al. Molecular and immunohistochemical analysis of the bcl-1/cyclin D1 gene in laryngeal squamous cell carcinomas: correlation of protein expression with lymph node metastases and advanced clinical stage. Cancer 1997;79:1114-21. https://doi.org/10.1002/(SICI)1097-0142(19970315)79:6<1114::AID-CNCR9>3.0.CO;2-F
- Hu H, Xia SH, Li AD, Xu X, Cai Y, Han YL, et al. Elevated expression of p63 protein in human esophageal squamous cell carcinomas. Int J Cancer 2002;102:580-3. https://doi.org/10.1002/ijc.10739
- Shah RB, Zhou M, LeBlanc M, Snyder M, Rubin MA. Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer. Am J Surg Pathol 2002;26:1161-8. https://doi.org/10.1097/00000478-200209000-00006
- Castle JT, Cardinali M, Kratochvil FJ, Abbondanzo SL, Kessler HP, Auclair PL, et al. P53 and cyclin D1 staining patterns of malignant and premalignant oral lesions in age-dependent populations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:326-32. https://doi.org/10.1016/S1079-2104(99)70037-5
- Poon RYC. Cell cycle control. Encyclopedia Cancer 1997;1:246-55.
- Kumar V, Cotran RS, Robbins SL. Robbins basic pathology. 7th ed. Philadelphia: Saunders; 2003.
- Weinstein IB, Zhou P. Cell cycle control gene defects and human cancer. Encyclopedia Cancer 1997;1:256-67.
- Mate JL, Ariza A, Aracil C, Lopez D, Isamat M, Perez-Piteira J, et al. Cyclin D1 overexpression in non-small cell lung carcinoma: correlation with Ki67 labelling index and poor cytoplasmic differentiation. J Pathol 1996;180:395-9. https://doi.org/10.1002/(SICI)1096-9896(199612)180:4<395::AID-PATH688>3.0.CO;2-C
- Angadi PV, Krishnapillai R. Cyclin D1 expression in oral squamous cell carcinoma and verrucous carcinoma: correlation with histological differentiation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103:e30-5.
- Lam KY, Ng IO, Yuen AP, Kwong DL, Wei W. Cyclin D1 expression in oral squamous cell carcinomas: clinicopathological relevance and correlation with p53 expression. J Oral Pathol Med 2000;29:167-72. https://doi.org/10.1034/j.1600-0714.2000.290404.x
- Goto H, Kawano K, Kobayashi I, Sakai H, Yanagisawa S. Expression of cyclin D1 and GSK-3beta and their predictive value of prognosis in squamous cell carcinomas of the tongue. Oral Oncol 2002;38:549-56. https://doi.org/10.1016/S1368-8375(01)00121-X
- Bartkova J, Lukas J, Strauss M, Bartek J. Cell cycle-related variation and tissue-restricted expression of human cyclin D1 protein. J Pathol 1994;172:237-45. https://doi.org/10.1002/path.1711720303
- Zhang YJ, Jiang W, Chen CJ, Lee CS, Kahn SM, Santella RM, et al. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem Biophys Res Commun 1993;196:1010-6. https://doi.org/10.1006/bbrc.1993.2350
- Ruhul Quddus M, Latkovich P, Castellani WJ, James Sung C, Steinhoff MM, Briggs RC, et al. Expression of cyclin D1 in normal, metaplastic, hyperplastic endometrium and endometrioid carcinoma suggests a role in endometrial carcinogenesis. Arch Pathol Lab Med 2002;126:459-63.
- Tsuruta H, Sakamoto H, Onda M, Terada M. Amplification and overexpression of EXP1 and EXP2/Cyclin D1 genes in human esophageal carcinomas. Biochem Biophys Res Commun 1993;196:1529-36. https://doi.org/10.1006/bbrc.1993.2425
- Naitoh H, Shibata J, Kawaguchi A, Kodama M, Hattori T. Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Am J Pathol 1995;146:1161-9.
- Mills AA. p63: oncogene or tumor suppressor? Curr Opin Genet Dev 2006;16:38-44. https://doi.org/10.1016/j.gde.2005.12.001
- Foschini MP, Gaiba A, Cocchi R, Pennesi MG, Gatto MR, Frezza GP, et al. Pattern of p63 expression in squamous cell carcinoma of the oral cavity. Virchows Arch 2004;444:332-9. https://doi.org/10.1007/s00428-003-0969-x
- Bortoluzzi MC, Yurgel LS, Dekker NP, Jordan RC, Regezi JA. Assessment of p63 expression in oral squamous cell carcinomas and dysplasias. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;98:698-704. https://doi.org/10.1016/j.tripleo.2004.04.001
- Chen YK, Hsue SS, Lin LM. Expression of p63 protein and mRNA in oral epithelial dysplasia. J Oral Pathol Med 2005;34:232-9. https://doi.org/10.1111/j.1600-0714.2004.00277.x
- de Oliveira LR, Ribeiro-Silva A, Zucoloto S. Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma. J Oral Pathol Med 2007;36:191-7. https://doi.org/10.1111/j.1600-0714.2007.00517.x
- Saintigny P, El-Naggar AK, Papadimitrakopoulou V, Ren H, Fan YH, Feng L, et al. DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia. Clin Cancer Res 2009;15:6284-91. https://doi.org/10.1158/1078-0432.CCR-09-0498
- Takeda T, Sugihara K, Hirayama Y, Hirano M, Tanuma JI, Semba I. Immunohistological evaluation of Ki-67, p63, CK19 and p53 expression in oral epithelial dysplasias. J Oral Pathol Med 2006;35:369-75. https://doi.org/10.1111/j.1600-0714.2006.00444.x
- Vered M, Allon I, Dayan D. Maspin, p53, p63, and Ki-67 in epithelial lesions of the tongue: from hyperplasia through dysplasia to carcinoma. J Oral Pathol Med 2009;38:314-20.
- Choi HR, Batsakis JG, Zhan F, Sturgis E, Luna MA, El-Naggar AK. Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis. Hum Pathol 2002;33:158-64. https://doi.org/10.1053/hupa.2002.30722
- Sakiz D, Turkmenoglu TT, Kabukcuoglu F. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin. Pathol Res Pract 2009;205:589-94. https://doi.org/10.1016/j.prp.2009.01.010
- Moergel M, Abt E, Stockinger M, Kunkel M. Overexpression of p63 is associated with radiation resistance and prognosis in oral squamous cell carcinoma. Oral Oncol 2010;46:667-71. https://doi.org/10.1016/j.oraloncology.2010.06.012
- Chen YK, Hsue SS, Lin LM. Immunohistochemical demonstration of p63 in DMBA-induced hamster buccal pouch squamous cell carcinogenesis. Oral Dis 2003;9:235-40. https://doi.org/10.1034/j.1601-0825.2003.02920.x
- Faridoni-Laurens L, Bosq J, Janot F, Vayssade M, Le Bihan ML, Kaghad M, et al. P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63? Oncogene 2001;20:5302-12. https://doi.org/10.1038/sj.onc.1204687
- Shirendeb U, Hishikawa Y, Moriyama S, Win N, Thu MM, Mar KS, et al. Human papillomavirus infection and its possible correlation with p63 expression in cervical cancer in Japan, Mongolia, and Myanmar. Acta Histochem Cytochem 2009;42:181-90. https://doi.org/10.1267/ahc.09030
- Di Como CJ, Urist MJ, Babayan I, Drobnjak M, Hedvat CV, Teruya- Feldstein J, et al. p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 2002;8:494-501.
- Edwards PC, Bhuiya T, Kelsch RD. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97:613-9. https://doi.org/10.1016/j.tripleo.2003.09.010
피인용 문헌
- CDK4, CDK6, cyclin D1 and Notch1 immunocytochemical expression of oral brush liquid‐based cytology for the diagnosis of oral leukoplakia and oral cancer vol.48, pp.7, 2017, https://doi.org/10.1111/jop.12902
- The Expression of p63 Protein in Different Grades of Oral Squamous Cell Carcinoma- An Immunohistochemical Study vol.8, pp.44, 2017, https://doi.org/10.14260/jemds/2019/723
- Prognostic Role of Epithelial-Mesenchymal Transition Markers “E-Cadherin, β-Catenin, ZEB1, ZEB2 and p63” in Bladder Carcinoma vol.10, pp.6, 2017, https://doi.org/10.14740/wjon1234
- Modulating effect of hesperetin on the molecular expression pattern of apoptotic and cell proliferative markers in 7,12-dimethylbenz(a)anthracene-induced oral carcinogenesis vol.126, pp.5, 2017, https://doi.org/10.1080/13813455.2018.1555600
- Differential Expression of Potential Biomarkers of Oral Squamous Cell Carcinoma Development vol.15, pp.4, 2017, https://doi.org/10.1007/s12105-021-01322-8